Persistent URL of this record https://hdl.handle.net/1887/112942
In Collections
This item can be found in the following collections:
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
- All authors
- Boer, S.M. de; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M.H.; Kitchener, H.C.; Nijman, H.W.; Kruitwagen, R.F.; Nout, R.A.; Verhoeven-Adema, K.W.; Smit, V.T.; Putter, H.; Creutzberg, C.L.; PORTEC Study Grp
- Date
- 2016-08-31
- Journal
- The Lancet Oncology
- Volume
- 17
- Issue
- 8
- Pages
- 1114 - 1126